Metabolic syndrome and pharmacotherapy outcomes in patients with type 2 diabetes mellitus.

Background: Metabolic syndrome is a group of metabolic abnormalities that increase predisposition to several diseases including ischemic heart disease and diabetes mellitus. The study aimed to investigate metabolic syndrome among patients with type-2 diabetes mellitus (DM), and its impact on pharmacotherapy outcomes.

Methods: An observational cross-sectional study was performed on 910 patients with type-2 DM between June and December 2023.